These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1521559)

  • 21. Amelioration of ischemia/reperfusion-induced myocardial infarction by the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146).
    Sasamori J; Aihara K; Yoneyama F; Sato I; Kogi K; Takeo S
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):614-20. PubMed ID: 16680077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium chloride-induced cardiovascular changes in rabbits are mediated by adenosine triphosphate-sensitive potassium channels.
    Abdel-Zaher AO; Abdel-Rahman MM
    Pharmacol Res; 1999 Apr; 39(4):275-82. PubMed ID: 10208757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous adenosine does not activate ATP-sensitive potassium channels in the hypoxic guinea pig ventricle in vivo.
    Xu J; Wang L; Hurt CM; Pelleg A
    Circulation; 1994 Mar; 89(3):1209-16. PubMed ID: 8124809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenomedullin synergistically interacts with endogenous vasodilators in rats: a possible role of K(ATP) channels.
    Sakai K; Saito K; Ishizuka N
    Eur J Pharmacol; 1998 Oct; 359(2-3):151-9. PubMed ID: 9832386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of adenosine on optic nerve head circulation in rabbits.
    Hirao M; Oku H; Goto W; Sugiyama T; Kobayashi T; Ikeda T
    Exp Eye Res; 2004 Nov; 79(5):729-35. PubMed ID: 15500831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.
    Levens N; Beil M; Jarvis M
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1005-12. PubMed ID: 2046017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide.
    Ogawa N; Fukata Y; Kaneta S; Jinno Y; Fukushima H; Nishikori K
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):11-7. PubMed ID: 1383619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase.
    Kleppisch T; Nelson MT
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12441-5. PubMed ID: 8618917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The involvement of ATP-sensitive potassium channels and adenosine in the regulation of coronary flow in the isolated perfused rat heart.
    Randall MD
    Br J Pharmacol; 1995 Dec; 116(7):3068-74. PubMed ID: 8680745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
    Webb RL; Barclay BW; Graybill SC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels.
    Toombs CF; McGee DS; Johnston WE; Vinten-Johansen J
    Cardiovasc Res; 1993 Apr; 27(4):623-9. PubMed ID: 8324796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-0861 selectively antagonizes adenosine A1 receptors in vivo.
    Barrett RJ; Droppleman DA; Wright KF
    Eur J Pharmacol; 1992 May; 216(1):9-16. PubMed ID: 1526257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-(1-Hexyn-1-yl)adenosine-induced intraocular hypertension is mediated via K+ channel opening through adenosine A2A receptor in rabbits.
    Konno T; Uchibori T; Nagai A; Kogi K; Nakahata N
    Eur J Pharmacol; 2005 Aug; 518(2-3):203-11. PubMed ID: 16023100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo K channel-opening effects of Ki3315, a metabolite of the novel vasodilator KRN2391.
    Tanaka Y; Okada Y; Yokoyama T; Nakajima T; Izawa T; Fukushima H; Ogawa N
    Arch Int Pharmacodyn Ther; 1993; 326():62-71. PubMed ID: 8185414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of K+ATP channel and adenosine receptor blockade during rest and exercise in congestive heart failure.
    Traverse JH; Chen Y; Hou M; Li Y; Bache RJ
    Circ Res; 2007 Jun; 100(11):1643-9. PubMed ID: 17478726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early administration of YT-146, an adenosine A2 receptor agonist, inhibits neointimal thickening after rat femoral artery endothelium injury.
    Takiguchi Y; Nagano M; Ikeda Y; Nakashima M
    Eur J Pharmacol; 1995 Aug; 281(2):205-7. PubMed ID: 7589208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of K(ATP)(+) channels and adenosine in the control of coronary blood flow during exercise.
    Richmond KN; Tune JD; Gorman MW; Feigl EO
    J Appl Physiol (1985); 2000 Aug; 89(2):529-36. PubMed ID: 10926635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of norepinephrine release by ATP-dependent K(+)-channel activators and inhibitors in guinea-pig and human isolated right atrium.
    Oe K; Sperlágh B; Sántha E; Matkó I; Nagashima H; Foldes FF; Vizi ES
    Cardiovasc Res; 1999 Jul; 43(1):125-34. PubMed ID: 10536697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs.
    Gerencer RZ; Finegan BA; Clanachan AS
    Br J Pharmacol; 1992 Dec; 107(4):1048-56. PubMed ID: 1467827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition by E4080, a novel bradycardic agent, of positive chronotropic responses to norepinephrine in isolated dog hearts.
    Sawaki S; Furukawa Y; Inoue Y; Oguchi T; Chiba S
    Eur J Pharmacol; 1993 Dec; 250(2):253-9. PubMed ID: 7509284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.